and chemical firms Epoch Biodesign has announced it has raised $18.3m to accelerate its efforts to harness plastic-eating enzymes to make recycled plastics cheaper and higher performing than ...

TechCrunch recently profiled Epoch Biodesign, a company that's been working to take founder Jacob Nathan's highschool project worldwide. The startup has just received $18.3 million in Series A ...

Founded in 2019 in London, Epoch Biodesign is now a 30+ strong multidisciplinary team of chemists, biologists, and software engineers. The startup will use the new funding to scale up production ...

Epoch Biodesign Research and Development Laboratory. Credits: Epoch Biodesign. Disruptive British start-up Epoch Biodesign has announced the closing of a Series A financing round of 18.3 million ...

Epoch Biodesign, a UK-based innovator in biorecycling, has successfully raised $18.3 million in its Series A funding round, with Goodwin Procter advising the startup. The funding will help the company ...

Epoch BioDesign has raised $18.3 million in Series A funding. The investment will support the company’s use of enzymes in recycling plastics. Traditional mechanical recycling struggles with mixed ...

London-based Epoch Biodesign has raised $18.3M (nearly €17.1M) in an oversubscribed Series A funding round. The company develops enzymes to improve the cost and performance of recycled plastics ...